(WASHINGTON, November 23, 2016) – The American Society of Hematology (ASH) today announced the recipients of its 2017 Scholar Awards. One of ASH's most prestigious award programs, the ASH Scholar Awards financially support fellows and junior faculty dedicated to careers in hematology research as they transition from training programs to careers as independent investigators.
Each Scholar Award provides up to $100,000 for fellows and $150,000 for junior faculty over a two- to three-year period. The program funds hematologists in North America who conduct basic, translational, and clinical research that furthers the understanding and treatment of blood disorders. ASH Scholar Awards are made possible through support from the ASH Foundation as well as from the corporate community, individual donors, and funds committed by the Society. ASH recognizes this year's corporate supporters, Janssen and Incyte.
"This award has launched the careers of many independent researchers in hematology," said ASH President Charles S. Abrams, MD, of the University of Pennsylvania. "The scholars we are supporting today have demonstrated creativity and commitment to hematology research, and I have no doubt that their studies will lead to important discoveries in our understanding of blood diseases, treatment, and patient care."
The 2016 Scholar Awards recipients are:
Basic Research Fellows
Grazia Abou Ezzi, PhD
Washington University School of Medicine in St. Louis, MO
Kelly Arcipowski, PhD
Northwestern University
Evanston, IL
Jeevisha Bajaj, PhD,
University of California – San Diego
La Jolla, CA
Tae Kon Kim, MD, PhD
Yale University
New Haven, CT
Kellie Machlus, PhD
Brigham and Women's Hospital
Boston, MA
Anna Protopopova, PhD
University of Pennsylvania School of Medicine
Philadelphia, PA
Marco Ruella, MD
University of Pennsylvania
Philadelphia, PA
Zuzana Tothova, MD, PhD
Dana-Farber Cancer Institute
Boston, MA
Andrew Volk, PhD
Northwestern University
Evanston, IL
Clinical Research Fellows
Melanie Fields, MD, MSCI
Washington University School of Medicine in St. Louis, MO
Erin Peckham-Gregory, PhD, MPH
Baylor College of Medicine
Houston, TX
Eric Smith, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY
Basic Junior Faculty
Margarida Almeida Santos, PhD, MS, BS
The University of Texas MD Anderson Cancer Center
Houston, TX
Craig Byersdorfer, MD, PhD
University of Pittsburgh School of Medicine
Pittsburgh, PA
Shuaiying Cui, PhD
Boston Medical Center
Boston, MA
Jarrod Dudakov, PhD
Fred Hutchinson Cancer Research Center
Seattle, WA
Renata Grozovsky, PhD
Brigham and Women's Hospital
Boston, MA
Sanggu Kim, PhD
The Ohio State University
Columbus, OH
Dan Landau, MD, PhD
Weill Cornell Medicine/New York Genome Center
New York, NY
Emily Mace, PhD
Baylor College of Medicine
Houston, TX
Jeffrey Magee, MD, PhD
Washington University School of Medicine
St. Louis, MO
Christopher Ott, PhD
Dana-Farber Cancer Institute
Boston, MA
Elli Papaemmanuil, PhD
Memorial Sloan Kettering Cancer Center
New York, NY
Vikram Paralkar, MD
University of Pennsylvania
Philadelphia, PA
Clinical Junior Faculty
Premal Lulla, MD
Baylor College of Medicine
Houston, TX
Alice Mims, MD, MSCR
The Ohio State University
Columbus, OH
Hong Zheng, MD, PhD
The Pennsylvania State University College of Medicine
Hershey, PA
Joanne Levy, MD, Memorial Award for Outstanding Achievement
Christopher Sturgeon, PhD, of Washington University School of Medicine in St. Louis, MO, will receive the 2016 Joanne Levy, MD, Memorial Award for Outstanding Achievement. This award is made possible by the family of past ASH Scholar Award recipient and distinguished Society member Joanne Levy, MD, who passed away in 2004. It is presented to the current ASH Scholar with the highest-scoring abstract for the ASH Annual Meeting, as determined by the appointed abstract reviewers.
Dr. Sturgeon received his doctorate degree from the University of British Columbia and is currently an assistant professor in the Division of Hematology of the Department of Medicine at Washington University School of Medicine in St. Louis. He is being honored for his oral abstract (Publication #883), "Human Definitive Hematopoietic Specification from Pluripotent Stem Cells Is Regulated by Mesodermal Expression of CDX4."
###
About the American Society of Hematology
The American Society of Hematology (ASH) is the world's largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood. For more than 50 years, the Society has led the development of hematology as a discipline by promoting research, patient care, education, training, and advocacy in hematology. The official journal of ASH is Blood, the most cited peer-reviewed publication in the field, which is available weekly in print and online.
About the ASH Foundation:
The ASH Foundation is dedicated to moving hematology forward through support of research, career development, and quality care and education programs. The ASH Foundation is supported through funding, resources, and leadership provided by ASH, the premier organization for physicians and scientists studying and treating blood disorders, and provides a mechanism for ASH members to give in support of critical programs. Personal donations to the ASH Foundation allow the Society to do more for hematology through the expansion or enhancement of existing programs.
Media Contact
Sara Khalaf
[email protected]
202-552-4925
@Bloodjournal
http://www.hematology.org
############
Story Source: Materials provided by Scienmag
